Officers and Board

Get Involved

We would love to hear from you!  We're always looking for existing members that may wish to be more involved with ISTU, and want to serve on our committees working with our board members to help guide on our key initiatives. Also, please let us know if you are interested in open positions that may be available on our Board of Directors in the next term.

Please send any questions, suggestions or comments to our board members via an email to admin@istu.org.

Meet the Executive Committee

President, Term Through ISTU 2027

Elisa E. Konofagou, Ph.D.
Columbia University

Elisa Konofagou is the Robert and Margaret Hariri Professor of Biomedical Engineering and Professor Radiology as well as Director of the Ultrasound and Elasticity Imaging Laboratory at Columbia University in New York City. Her main interests are in the development of novel theranostic and therapeutic ultrasound methods for the advancement of therapeutic ultrasound. Her group has been working in the field for more than 18 years with applications in breast and pancreatic cancer ablation monitoring as well as brain therapeutics that involve drug delivery through the blood-brain barrier. Elisa has co-authored over 270 published articles in the aforementioned fields. She is recipient of the CAREER award by the National Science Foundation (NSF), the Nagy award by the National Institutes of Health (NIH), the Technological Achievement Award by the Institute of Electrical and Electronic Engineers (IEEE) Engineering in Medicine and Biology society (EMBS), the Carl Hellmuth Hertz Ultrasonics Award by the IEEE Society in Ultrasonics, Ferroelectrics and Frequency Control (UFFC) gas well as additional recognitions by the American Heart Association, the Acoustical Society of America, the American Institute of Ultrasound in Medicine, the American Association of Physicists in Medicine, the Wallace H. Coulter foundation, the Bodossaki foundation, the Society of Photo-optical Instrumentation Engineers (SPIE) and the Radiological Society of North America (RSNA).

Secretary General, Term Through ISTU 2027

Antonios Pouliopoulos, Ph.D.
King's College London

Dr. Pouliopoulos received his B.Sc. in Physics from Aristotle University of Thessaloniki in 2011, with a specialization in solid state physics. As an undergraduate student, he conducted research in thin film characterization using X-ray absorption spectroscopy in the University of Bologna, Italy, and the European Synchrotron Radiation facility in Grenoble, France. He earned his M.Sc. in Nanotechnology and Regenerative Medicine from University College London, United Kingdom, in 2013, where he conducted research on positron emission mammography and magnetic resonance imaging using superparamagnetic iron oxide nanoparticles as contrast agents. He obtained his Ph.D. in Bioengineering from Imperial College London, United Kingdom, in 2017, for his work on controlling microbubble dynamics in ultrasound therapy. During his Ph.D., he developed multiple techniques in the field of therapeutic ultrasound, including rapid short-pulse therapy, Doppler passive acoustic mapping, and optical methods for investigating microbubble motion during ultrasound exposure. He worked as a postdoctoral research scientist and an associate research scientist in the Ultrasound Elasticity Imaging Laboratory at Columbia University, in New York City, NY, USA, from 2017 to 2021. Starting November 2021, he is a lecturer in therapeutic ultrasound in the Department of Surgical and Interventional Engineering at King’s College London. He has received multiple awards and serves as a reviewer for 25 international peer-reviewed journals. He has mentored over 80 high-school, undergraduate and graduate students in their research projects and has been involved in outreach events promoting scientific research to the community. His research interests include targeted drug delivery using ultrasound, microbubble dynamics in ultrasound therapy, ultrasound therapy monitoring, and clinical translation of therapeutic ultrasound.

Treasurer, Term Through ISTU 2027

Natasha D. Sheybani, Ph.D.
University of Virginia

Dr. Sheybani is an Assistant Professor of Biomedical Engineering and (by courtesy) of Radiology & Medical Imaging and Neurosurgery at the University of Virginia. Dr. Sheybani leads a translational research program centered on advancing focused ultrasound into the era of precision immuno-oncology for solid tumors of the brain and periphery. Her research interests include immunotherapy delivery, immuno-modulation, liquid biopsy, molecular imaging and imaging informatics. The Sheybani laboratory interfaces closely with multiple ongoing clinical trials at UVA that are evaluating combinatorial focused ultrasound and immunotherapy in metastatic breast cancer and other solid tumor settings.

Immediate Past President, Term Through ISTU 2027

Cyril Lafon, Ph.D.
Research Director,
Head of LabTau, INSERM

Dr. Lafon earned his B.Sc. degree in Physics from University Blaise Pascal of Clermont Ferrand, France and University of Montreal, Quebec, in 1995, and his Ph.D. degree in Biomedical Engineering from University Claude Bernard of Lyon, France, in 1999. After developing interstitial HIFU probes during his Ph.D. study in INSERM Unit 281, Dr. Lafon joined for two years the Applied Physics Laboratory of the University of Washington, Seattle, as a postdoctoral research fellow. Dr. Lafon worked there on ultrasound induced hemostasis and the development of tissue mimicking phantoms for HIFU applications. Dr. Lafon was recruited by INSERM, Unit 556, in 2002 as a research scientist. He is now research director and head of LabTAU, INSERM Unit 1032. His recent research interests focus on modeling ultrasound wave propagation, development of ultrasonic therapeutic devices for thermal ablation or drug delivery and communication by ultrasound for medical applications. In July 2016 and for one year, Cyril Lafon joined the department of radiation oncology of the University of Virginia in Charlottesville (USA).

President-Elect, Term Through ISTU 2030

Allison Payne, Ph.D.
Professor and Vice Chair of Research in Radiology and Imaging Sciences, University of Utah

Allison Payne, Ph.D., is Professor and Vice Chair of Research in Radiology and Imaging Sciences at the University of Utah and the John Henry and Nancy LeNore Parker Endowed Chair in Medical Imaging Research. She earned her Ph.D. in Mechanical Engineering with an emphasis in bioheat transfer from the University of Utah in 2008 and completed postdoctoral training in medical imaging at the Utah Center for Advanced Imaging Research in 2011. She leads a multidisciplinary research program focused on advancing image-guided therapeutic ultrasound. Her laboratory develops and translates focused ultrasound approaches for the treatment of breast cancer, alongside innovations in magnetic resonance and ultrasound imaging to quantify bioeffects in vivo. Her team also explores neuromodulation and pain applications, while advancing MR thermometry, MR shear wave elastography, and hardware innovations to improve MR-guided focused ultrasound therapies. Her work has been supported primarily by the National Institutes of Health, as well as the U.S. Department of Defense, foundations, and institutional funding mechanisms.

A committed and long-standing member of the scientific community, Dr. Payne has dedicated significant effort to professional service and leadership. She has held elected and appointed roles across multiple organizations, including the International Society of Therapeutic Ultrasound (ISTU), the International Society for Magnetic Resonance in Medicine (ISMRM), the Society of Thermal Medicine (STM), and the American Association of Physicists in Medicine (AAPM). She currently serves as Chair of the NIH Imaging-Guided Interventions and Surgery Study Section and is a Distinguished Investigator of the Academy for Radiology and Biomedical Imaging Research. Dr. Payne has been an active member of ISTU since attending her first meeting as a doctoral student in 2005. She deeply values the society’s supportive and collaborative culture, particularly its commitment to trainees and early-career investigators. Throughout her career, she has worked to foster inclusive mentorship, interdisciplinary collaboration, and translational impact.

Executive Director Since 2018

Shelly Reid, M.B.A.

Meet the Board

Members of the Board are elected by ISTU members during the annual elections and are announced at each annual Symposium meeting. Board Members serve for a period of 3 years.

Board Members: Term through ISTU 2027

Jürgen Götz, Ph.D. - Geographic Region: Asia / Australasia Representative
Queensland Brain Institute in Brisbane, Australia

Professor Jürgen Götz is the inaugural Director of the Clem Jones Centre for Ageing Dementia Research at the Queensland Brain Institute in Brisbane (Australia). Professor Götz studied biochemistry in Switzerland and earned his PhD in immunology with Nobel Laureate Köhler in Germany. After postdoctoral work at UCSF and at Novartis, he became a group leader in Zürich, before moving to the University of Sydney in 2005, and then to the University of Brisbane (Queensland Brain Institute) in 2012. A major focus of his laboratory is to gain insight into how tau and amyloid both separately and synergistically contribute to Alzheimer’s disease. In recent years, the laboratory has started to develop therapeutic ultrasound into a treatment modality for Alzheimer’s disease and other brain diseases, both by transiently opening the blood-brain barrier and as a neuromodulatory tool.

Klazina Kooiman, Ph.D. - Geographic Region: Europe/Africa/Middle East Representative
Associate Professor
LabTAU (INSERM), Lyon, France
Biomedical Diagnostics Lab,
Eindhoven University of Technology, Eindhoven, the Netherlands

Klazina Kooiman received the M.Sc. degree with honors (cum laude) in Biopharmaceutical Sciences, specializing in pharmaceutical technology, from Leiden University, Leiden, the Netherlands, in 2000, and the Ph.D. degree in ultrasound contrast agents for therapy from the Department of Biomedical Engineering, Thoraxcenter, Erasmus MC University Medical Center Rotterdam, the Netherlands, in 2011. Following her Ph.D., she held successive academic positions at Erasmus MC University Medical Center Rotterdam, first as a postdoctoral fellow, then as Assistant Professor (2015–2020), and subsequently as Associate Professor (2020–2025) in the Department of Biomedical Engineering, Thoraxcenter. In 2013, she was a visiting scholar at the University of Pittsburgh Medical Center (UPMC), Pittsburgh, PA, USA.

She is currently an Associate Professor at LabTAU (INSERM) in Lyon, France, and at the Biomedical Diagnostics Lab, Eindhoven University of Technology, Eindhoven, the Netherlands. Her research focuses on the theragnostic field of ultrasound-activated microbubbles (1–8 µm) for local drug delivery and ultrasound molecular imaging of cardiovascular disease and cancer. To elucidate the mechanisms of microbubble-mediated drug delivery, she employs multidisciplinary translational approaches at the interface of engineering, biology, and pharmacy.
Her research targets endothelial cells for vascular drug delivery and bacterial biofilms in infective endocarditis, including infections associated with cardiac devices. She is the co-director of the annual European Symposium on Ultrasound Contrast Imaging and co-chair of the Contrast Agents Track of the IEEE International Ultrasonics Symposium. She has served as a board member of the International Society for Therapeutic Ultrasound (ISTU) since September 2024.

Adam Maxwell, Ph.D. - Geographic Region: The Americas Representative
Virginia Tech

Dr. Maxwell is a Research Associate Professor in the Department of Biomedical Engineering and Mechanics at Virginia Tech. He has been involved in focused ultrasound research for over 20 years. His work centers on understanding and controlling mechanical effects of focused ultrasound to disintegrate soft tissues (histotripsy) and calcifications (lithotripsy). He is the lead inventor of burst wave lithotripsy, a focused ultrasound technique to fragment urinary stones. He has overseen most of the preclinical and technological development of burst wave lithotripsy, which is now in clinical trials. His other expertise includes acoustic modeling, ultrasound electronics, and piezoelectric transducer design and fabrication.

George R. Schade, M.D - Clinical Representative
University of Washington

George R. Schade, MD is an Associate Professor of Urology at the University of Washington. He completed his undergraduate and medical education at the University of Chicago, his Urology Residency at the University of Michigan, and SUO fellowship at the University of Washington. During his residency and fellowship he completed post-doctoral research training in the field of historipsy with Will Roberts, MD and Vera Khohklova, PhD. As a clinician-scientist he leads an R01 funded translational science program aimed at developing therapeutic ultrasound and imaging applications, with emphasis on histotripsy, to reduce the burden of cancer on patients and improve their quality of life. He is the director of the UW Prostate Cancer Focal Therapy Program and member of the West Coast Focal Therapy Collaborative. He is an active user of clinically available therapeutic ultrasound systems using HIFU to treat prostate cancer and investigate clinical outcomes of HIFU. Additionally, he is an active educator training the next generation of clinicians on the benefits of, indications for, and how to perform HIFU. He has been an active participant in ISTU for >10 years and is serving his second term on the ISTU board.

Rosie Xing, Ph.D - Industry Representative
Laboratory of Cancer Stem Cell Translational Research Laboratory at Chongqing Medical University

Dr. Xing is a professor and the Director of the Laboratory of Cancer Stem Cell Translational Research Laboratory at Chongqing Medical University (P. R. China). Her research interests are primarily in modulation of tumor microenvironment in cancer metastasis, characterization and regulation of cancer stem cell properties, and the bioeffects and underlying mechanisms related to HIFU cancer treatment. Professor Xing is also the Managing Director of the International Business at Chongqing Haifu Medical. She is in charge of International Academic Exchanges, Global Planning, International Marketing and Business.

Board Members: Term through ISTU 2028

Costas D. Arvanitis, Ph.D. - Geographic Region: The Americas Representative
Georgia Institute of Technology and Emory University

Dr. Arvanitis is a joint Associate Professor at the Woodruff School of Mechanical Engineering and the Coulter Deparment of Biomedical Engineering at Georgia Institute of Technology and Emory University (2016-present). Dr. Arvanitis completed his doctoral studies at University College London at the Department of Medical Physics and Bioengineering in 2008. Subsequently, he did a two-year postdoctoral fellowship (2008-2009) at the Institute of Biomedical Engineering at the University of Oxford. He then carried on with his research at Harvard Medical School and Brigham and Women’s Hospital (2010-2016), where he reached the rank of Instructor. Dr. Arvanitis’ research integrates medical ultrasonics, quantitative imaging, mathematical modeling, and in vitro/in vivo experimentation to support the discovery and translation to the clinics of novel diagnostic and therapeutic interventions against human disease. Specific areas of his research include targeted cell and gene delivery, cell-based diagnostics and therapeutics, image guided therapy, and cancer research. His lab has pioneered methods and technology for monitoring, mapping, and controlling microbubble dynamics in the brain and provided new insights on ultrasound mediated mas transport and immune cell trafficking in brain tumors. Dr. Arvanitis’ research is regularly disseminated at top tier multidisciplinary journals (PNAS 2018, Nature Review Cancer 2020, Science Advances 2021 and 2022, and Nature Communications 2024). He is the recipient of the 2014 Roberts Prize for the best article published in the journal of Physics in Medicine and Biology in 2013 and the Pathway to Independence (2014) and MERIT (2020) Awards from the National Institute of Health (USA).

Ellen J. Bubrick, M.D. - Clinical Representative
Mass General Brigham, Boston, MA

Dr. Bubrick is a clinician-scientist in the field of neurology with specialized training and a busy clinical practice in epilepsy. Her research interests include developing novel non-pharmacologic treatments for drug-resistant epilepsy. She has been investigating using transcranial focused ultrasound (TUS) neuromodulation in this population. Dr. Bubrick was the principal investigator of the first clinical trial that modulated human hippocampus in patients with temporal lobe epilepsy using TUS. She obtained the first Investigational Device Exemption the FDA had approved for a clinical trial using serial treatments of TUS in humans with epilepsy. Initial report of the trial generated significant interest in the field of epilepsy and in the emerging field of focused ultrasound. Preliminary findings have been presented at several national institutions including the NIH, as well as at international conferences. Given Dr. Bubrick's experience spearheading clinical trials using TUS, she frequently reviews grants and advises on clinical trials for a wide range of transcranial applications. Dr. Bubrick serves on the Focused Ultrasound Foundation’s Scientific Advisory Board, where she is a thought leader for the future direction of future TUS clinical trials. She also serves on the only international consortium in the field, the International Transcranial Ultrasound Safety and Standards (ITRUSST), where she chaired the clinical research task force arm of this group. Many of these trials are still in the early safety phases, which dovetails with her work as a clinical safety expert, Dr. Bubrick serves as the Associate Chair for quality and safety for the department of neurology at Mass General Brigham in Boston, MA.

David Caumartin - Industry Representative
RebrAIn

David Caumartin started to collaborate with FUS foundation since 2014 as he was CEO of Theraclion, USgFUS solution for breast & Thyroid tumors and varicose veins. In 2023, he joined as senior partner helping on strategic development, market access and commercial development topics from Korea, Taiwan, European and USA based members. Since 2015, David has been at the Board of France Biotech and co-chaired as Vice-President of France Biotech since 2018 the MedTech & diagnostic group. Since January 2024, he has been CEO of RebrAIn, a company that has emerged from academic research at Bordeaux University Hospital and INRIA, offering a targeting service for neurosurgeons in charge of treating severe forms of neurological disease using DBS, Radiosurgery and of course MRgFUS.

Before he was CEO of Theraclion for eight years, he spent 15 years at GE Healthcare, including 5 years in the computed tomography & 5 years as VP of Global Mammography (screening, diagnosis by CAD system, review station and biopsy). After more than 25 years in the medical device ecosystem, David remains determined to accelerate the transformation of innovation into national, European and global successes. He truly believes therapeutic is the next frontier bring access and premium care for patient suffering from cardiovascular, oncologic but also neurologic disease which he serves now more than before.

David is more than ever motivated to accelerate the world healthcare transformation using AI as a mean to standardize, simplify and universalize the complex but meaningful impact that therapeutic ultrasound can do for industry, physicians & patients.

Lei Sun, Ph.D. - Geographic Region: Asia / Australasia Representative
Hong Kong Polytechnic University

Lei Sun, PhD is a Professor of Biomedical Engineering in the Hong Kong Polytechnic University. His recent research contributes to the understanding of cellular/molucular mechanism of ultrasound neuromodulation and the development of “sonogenetics” technique. His other research interests include the study of the interaction of ultrasound and ion channels, devising a “sonogenetics” method for other application (e.g. cancer and diabetes), and possible translational strategies. His continuous efforts in molecular ultrasound and photoacoustic imaging, and theranostics are also worth of mentioning.

Joan Vidal-Jové - Geographic Region: Europe/Africa/Middle East Representative
The Institute Khuab for Interventional Oncology

Joan Vidal-Jové is a surgical oncologist trained in Barcelona and Washington DC, and in Focused Ultrasound Ablation by the Second University of Chongqing, China. At present he runs a private tumor center in Barcelona, the Institute Khuab for Interventional Oncology and is a consultant in clinical research for Histosonics, Inc. He leaded the first oncological FUS-HIFU unit of his country from 2010 to 2020. Since then, he has performed more than 250 oncological cases with Focused Ultrasound, with special attention to pancreatic and liver tumors. He was the PI of the First in Human Study of Histotripsy in liver tumors and organized ISTU 2019 in Barcelona. Since then, he has been involved in the development of Histotripsy in clinical settings and researched the abscopal immune effect associated with it. At present, he is co-leading the First in Human Study of Histotripsy in pancreatic tumors in Hospital de la Santa Creu i Sant Pau, Barcelona.

Board Members: Term through ISTU 2029

Ayache Bouakaz, MSc, Ph.D. - Geographic Region: Europe/Africa/Middle East Representative
Inserm Imaging, Brain and Neuropsychiatry (iBraiN) Institute, University of Tours

Ayache Bouakaz received his MSc and PhD in acoustics from INSA Lyon, France, in 1992 and 1996. He subsequently held research positions at The Pennsylvania State University (USA) and Erasmus Medical Center (The Netherlands), where he worked on ultrasound imaging, contrast agents, and transducer design. Since 2004, he has been with Inserm, and since 2009 he has served as Research Director at the Inserm Imaging, Brain and Neuropsychiatry (iBraiN) Institute, University of Tours, France, where he leads the Group of Morphofunctional Imaging and Therapeutic Ultrasound. His research focuses on ultrasound contrast imaging, therapeutic ultrasound, drug delivery, neuromodulation, and transducer design. His work bridges fundamental acoustics, biomedical engineering, and clinical applications, with strong emphasis on translation toward patient care.

Mario Fabiilli, Ph.D. - Geographic Region: The Americas East Representative
Radiology and Biomedical Engineering, University of Michigan

Dr. Mario Fabiilli is an Associate Professor of Radiology and Biomedical Engineering at the University of Michigan. Before joining the academic ranks, he worked in the pharmaceutical industry as a formulation scientist. His research group develops ultrasound-responsive biomaterials for drug delivery and tissue regeneration, with a focus on leveraging phase-shift emulsions and acoustic droplet vaporization (ADV) to modulate biochemical and biophysical cues. His research interests include stimulating blood vessel growth to revascularize ischemic tissue, promoting host-graft vascular integration, controlling bone regeneration via the differentiation of mesenchymal stromal cells, and improving the function of transplanted islets for type I diabetes. He has co-authored over 75 peer-reviewed publications, and his research has been externally funded by the NIH and Focused Ultrasound Foundation. His lab has served as the training environment for postdoctoral fellows, graduate students, undergraduates, and high school students; in 2023, his mentoring efforts were recognized with the Michigan Institute for Clinical & Health Research Distinguished Mentor Award. He has been active in ISTU since he attended his first conference in 2009. He was awarded the Frederic Lizzi Early Career Award from ISTU in 2021. He is also involved in the ultrasound community through the Acoustical Society of America, where he has co-organized special sessions on ADV; the Gordon Research Conference on ultrasound, where he was elected co-vice chair for the 2026 meeting; and the Journal of Ultrasound in Medicine, where he serves on the advisory editorial board.

Ying Meng, BASc, M.D., Ph.D. - Clinical Representative
Sunnybrook Health Sciences Centre / University of Toronto

Dr. Ying Meng is a neurosurgeon scientist at Sunnybrook Health Sciences Centre, and Assistant Professor at the University of Toronto. She completed her residency training at the University of Toronto and her PhD work at Sunnybrook. Her research interest pertains to the application of transcranial focused ultrasound for blood-brain barrier disruption. With the team at Sunnybrook, she led some of the first clinical trials to test MR-guided focused ultrasound in patients with neurodegenerative disorders and brain tumors.

Himanshu Shekhar, Ph.D. - Geographic Region: Asia/Australasia Representative
Indian Institute of Technology (IIT) Gandhinagar

Himanshu Shekhar is an Associate Professor of Electrical Engineering at the Indian Institute of Technology (IIT) Gandhinagar, India, where he co-leads the Medical Ultrasound Engineering (MUSE) Laboratory. He obtained a bachelor’s in Electronics and Communication Engineering from the Manipal Institute of Technology, India, and a Master’s and Ph.D. in Electrical Engineering from the University of Rochester, USA. Dr. Shekhar trained as a postdoctoral fellow at the University of Cincinnati College of Medicine, U.S.A. Subsequently, he started his research group at IIT Gandhinagar and was promoted to Associate Professor in 2024. Dr. Shekhar’s research focuses on image-guided therapy, sonodynamic therapy, contrast agents, sensing, and beamforming. His work has been published in 40 peer-reviewed journal articles and presented at leading international symposia. Dr. Shekhar’s recognitions include the Howard Hughes Medical Institute’s Med-into-Grad Fellowship, the F. V. Hunt Postdoctoral Fellowship and Best Paper Awards from the Acoustical Society of America (ASA), the Har Govind Korana Innovative Young Biotechnologist Award from the Government of India, the Star Ambassador Lectureship Award from the IEEE Ultrasonics, Ferroelectrics and Frequency Control (UFFC) Society, and the Frederick Lizzi Early Career Award from the International Society for Therapeutic Ultrasound (ISTU). He serves on the IEEE International Ultrasonics Symposium (IUS) Technical Committee, and chairs the “Biomedical Effects and Dosimetry” track. He organized the IEEE South Asian Ultrasonics Symposium (SAUS) as General Chair (held in 2024 and scheduled in 2026). He also serves as Faculty Advisor to the ISTU Student Board and on the Scientific Advisory Board of Verasonics Inc., USA. Dr. Shekhar is passionate about advancing ultrasound for next generation healthcare by leveraging international cooperation and collaboration.

Emily White, M.D. - Industry Representative
Chief Medical Officer, Sonic Concepts

Emily White, M.D. is a physician-executive with deep experience in therapeutic and focused ultrasound commercialization, clinical translation, and industry partnership development. She currently serves as Chief Medical Officer at Sonic Concepts, where she helps guide company strategy and works closely with medical device innovators to advance technologies from concept to market with clinical and commercial alignment. Dr. White brings more than 30 years of experience spanning clinical medicine, technical startups, nonprofit leadership, grant writing, and business development. Her career has focused on translating complex technologies into viable clinical solutions and sustainable businesses. She holds an MD from the University of Virginia School of Medicine, a BS in Biology and Anthropology from Smith College, and certification in Community Conflict Resolution from Loyola Law School.

For ten years, Emily served as a Managing Director at the Focused Ultrasound Foundation, where she led both operations and the FUS Partners program—an initiative dedicated to supporting the focused ultrasound commercial community. In this role, she worked closely with manufacturers, investors, researchers, and strategic partners to strengthen collaboration, accelerate commercialization, and advance the field toward broader clinical adoption. Emily’s career reflects sustained engagement across industry, clinical practice, and nonprofit leadership within the focused ultrasound ecosystem. As an ISTU Board Member, she seeks to represent industry perspectives while supporting the society’s broader mission to advance therapeutic and focused ultrasound research, translation, and global impact.

Ex Officio Active Board Members

Ex Officio Previous Organizers
David Goertz, Ph.D., Co-Organizer, ISTU 2022, Term Through ISTU 2025
Jae-Young Lee, Co-Organizer, ISTU 2021, Term Through ISTU 2024
Joan Vidal-Jové, M.D., Ph.D., Organizer, ISTU 2019, Term Through ISTU 2022
Chrit Moonen, Organizer, ISTU 2015
Kim Butts-Pauly, Organizer, ISTU 2014
Guofeng Shen, Organizer, ISTU 2013
Stephen Meairs, Organizer, ISTU 2012
Elisa Konofagou, Co-Organizer, ISTU 2011
Robert Muratore, Co-Organizer, ISTU 2011